2025 DxPx U.S. Startups
EXHIBITING IN STARTUP CITY: 

 

Ad Astra Diganostics
Ad Astra Diagnostics delivers rapid, lab-grade blood analysis at the point of care with its QScout™ system. Designed for use anywhere—from emergency department to ambulances to urgent care—QScout provides a complete blood count in ~2 minutes using fingerstick or venous blood. 

 

Amadix
Founded in 2010, Amadix is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies to detect the tumor many years before the symptoms appear. The company’s products are oriented towards non-invasive early cancer detection, avoiding the complications of existing invasive procedures, such as tumor biopsies.

 

Annaida Technologies
Annaida Technologies, founded in 2019, is Swiss a high-tech stratup offering micro-NMR solutions for R&D and In Vitro Fertilization. Our technology, developed over years, demonstrates every day performance that redefine the state of art and allow to measure what is currently out of reach for the conventional instrumentation.

 

Axithra
Axithra is a spin-off from Ghent University and imec, developing a platform to quickly and accurately measure and monitor drug concentrations in blood, paving the way for treatments tailored to the specific needs of each individual, at any given time.

 

Bacteromic
The company develops technological projects for medical diagnostics and healthcare. The strategic goal of the Group is to generate profits as a result of sales of independently developed technology projects for global manufacturers of medical devices. The Scope Fluidics Group provides developed projects with financing, access to laboratories and workshops, and crucial administrative facilities and services.

 

BiopSense
BiopSense Oy is a medical technology company focusing on liquid biopsy services and technology development. Our invention is an automated device (cartridge) for cell-free nucleic acid extraction from large blood volumes (up to 12 ml) without the need for centrifugation or other manual steps.

 

Brand Institute
Brand Institute is the global leader in brand name and identity development. We provide a broad portfolio of services to our healthcare, consumer and business-to-business clients, including name development, trademark searches, market research, regulatory and visual identity solutions. 

 

Clinical Design Technologies

Accurate. Reliable. Effortless. UTS™️ revolutionizes point-of-care testing by combining trusted reagent chemistry with advanced reflectance photometry. This fully digital system eliminates manual timing and subjective colour interpretation—removing key failure points at the point of care and delivering consistent, high-precision urine analysis every time.

 

Cytophenix
Cytophenix is developing rapid antimicrobial susceptibility tests that offer accurate and timely results, with the mission of enhancing treatment recommendations for patients with serious life-threatening infections. Cytophenix’s innovative approach expedites the testing process without compromising accuracy. By swiftly identifying the most effective antibiotics for individual patients, informed treatment decisions can be made sooner.

 

Elligo Health Research
Elligo Health Research is an integrated research organization founded to bridge the gap between cutting-edge clinical trials and the patients who need them—an idea that sparked when our founder's barber couldn't access a promising treatment. By embedding research into routine care, Elligo empowers physicians to offer trials to their own patients, expanding access, improving diversity, and reducing barriers through additional travel and retention support services.

Genomadix Inc.
Based in Ottawa, Canada, Genomadix Inc. is a pioneer in real-time qPCR point of need technology, dedicated to the highest level of customer satisfaction, quality, and support, maintaining ISO 13485 medical device development and manufacturing standards certification. The Genomadix Cube is a real-time polymerase chain reaction (PCR) molecular diagnostic instrument capable of performing tests for precision medicine genotyping and environmental targets on a sample-to-result platform. The portable size, ease of use, and on-demand processing capability enables users to generate time-critical results in approximately one hour.

Genometec
Genomtec is a MedTech company specializing in the development of advanced technologies in the field of genetic diagnostics. The company's flagship project is the Genomtec ID mobile diagnostic system, which allows for fast and precise molecular analysis outside the laboratory environment without the need to involve qualified laboratory personnel. The company has EU CE-IVD certification for the Genomtec ID RP5-PLEX diagnostic panel, which simultaneously detects the presence of the most common respiratory tract infections.

 

Genomill
Our team brings together experienced scientists, entrepreneurs, and visionaries who share a passion for precision diagnostics and genomic technologies.

 

Ginolis
Ginolis specializes in precision robotics in assembly automation, high precision liquid handling and quality inspection solutions for the global medical device and diagnostics industries as well as other robot applications.

Hylid Diganostics
Home testing and remote care for chronic diseases. Hylid Diagnostics (HyliDx) will improve the lives of millions of people with kidney disease and heart failure, saving healthcare systems thousands of dollars per patient each year.

 

Loop Diagnostics
Loop Diagnostics is a biotech company that develops a diagnostic tool for sepsis, using an in vitro cellular immunoassay to detect it within the first hour of bloodstream infection. Their goal is to reduce disease severity and mortality rates through timely and effective treatment.

 

Macula Vision Systems
Macula is transforming clinical microscopy workflow by deploying a compact and rapid computational imaging platform to enable true hands-off automation. Your whole slide is scanned and interpreted on-board leveraging latest AI/ML architectures in minutes. Report and high-fidelity images are available on the system for local or remote review.

MLA Diagnostics
MLA Diagnostics’ innovative product is an in vitro diagnostic (IVD) method that is able to determine melanoma patients with low or high metastatic risk. Performed by the pathologist, this test provides more insight on a patients’ expected outcome and will enable a different course of treatment (more or less intensive).

 

Nadmed
NADMED Oy is a startup company bringing to market a new accurate high-throughput method to measure NADs from whole blood and other sample matrices.

 

Novel Biomarkers Catalyst Lab
NBCL has developed a point of care analyzer with a five-minute whole blood intact PTH assay that can be operated by anyone. NBCL offers assay development for your biomarkers on the NBCL point of care analyzer or on your platform.

 

Now Diagnostics
The future of diagnostic testing is shifting—from the lab to your kitchen table and the hospital bedside—and NOWDiagnostics (NOWDx) is leading the way.
 
NOWDx is an early-growth diagnostics company at the forefront of over-the-counter (OTC) and hospital testing. The company has lateral flow and a molecular diagnostic platforms in blood and saliva – both are disposable and affordable and can be performed in 15 minutes or less.
 
The company has launched an FDA marketing authorized syphilis test that is available in over 16,000 retail stores. Its early pregnancy test is also approved for OTC use in the EU and cleared under 510(k) for use by laboratory professionals in a hospital setting with many other tests in the pipeline.
 
Visit firsttoknow.com and nowdx.com to learn more.

 

Pando Bioscience
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical manufacturing and diagnostics industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods.

 

Prolight Diagnostics
Prolight Diagnostics AB develops innovative Point-of-Care (POC) systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events.

 

RICOVR Healthcare
RICOVR Healthcare, based in Princeton, NJ, is the creator of the XALIVA® rapid diagnostics platform that provides high-quality, rapid diagnostic results using only a small amount of saliva. The company’s product pipeline includes rapid point-of-care tests for THC, drugs-of-abuse, reproductive health, and infectious diseases. RICOVR is proud to be guided by a distinguished advisory board and management team of scientists and engineers committed to positively impacting society. In addition, the company has strong partnerships with leading research institutions and medical device manufacturing companies around the globe. 

 

Scope Biosciences
Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.

 

Signal Bioscience
We are a market-led research organisation which has pioneered an innovative process for product development. We marry leading-edge biochemical insights, systems thinking, and pragmatism in the selection and development of bioactives. The results are safe, effective, market-ready solutions for businesses in the consumer health sector.  Signal’s evidence-based solutions confer a defensible competitive advantage to our customers.

 

STRATEC
STRATEC designs and manufactures fully automated analyzer systems, software and smart consumables for its partners in the fields of clinical diagnostics and life sciences. Building on an unparalleled breadth of technology and the expertise gained in more than forty years of automating laboratory processes, STRATEC has established itself as one of the world’s leading providers of automation solutions for in-vitro diagnostics and life science companies.

 
 

Surfixdx
Surfix is redefining point-of-care diagnostics with an innovative Photonic Diagnostic Platform; a multi-modal solution that combines superior precision for protein detection over current lab-testing platforms with the speed and simplicity of point-of-care testing. As a rapidly growing startup, our focus is on strategic partnerships for co-developing immunoassays with diagnostic, biomarker discovery, and biopharmaceutical companies and then expanding our platform to include molecular and combined capabilities.

 

Vector
World's First Real-Time Mosquito Pathogen Surveillance. Vector Dx develops real-time diagnostic sensors for both supervised laboratory and autonomous field use. Our platform combines multiplex qPCR with advanced algorithms to detect mosquito-borne viruses like dengue, West Nile, and even malaria. Designed for simplicity and speed, our systems bring high-performance molecular diagnostics to the front lines of public health.

We Venture Capital
We Venture Capital is the corporate venture arm of Werfen, a worldwide leader in Specialized Diagnostics. We invest in early-stage start-ups close to market entry, or early scale-ups. We combine the agility of a VC with an unique understanding of the diagnostics sector, empowering startups with strategic insight, global reach, and deep diagnostics know-how.